Jonathan S Foot (Jonathan Foot)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Reactive Oxygen Species

Duchenne Muscular Dystrophy

Top Venues

Antioxidants (Basel, Switzerland)

Journal of medicinal chemistry

Pharmaxis Ltd

University of YorK (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pharmaxis Ltd Oct 30 2006

Australia

Senior Research Scientist :: Drug discovery

Education History

University of YorK

United Kingdom

PHD :: Chemistry

Publications

Francesca Gasparella, Leonardo Nogara, Elena Germinario, Lucia Tibaudo, Stefano Ciciliot, Giorgia Piccoli, Francisca Carolina Venegas, Francesca Fontana, Gabriele Sales, Daniele Sabbatini, Jonathan S Foot, Wolfgang Jarolimek, Bert Blaauw, Marcella Canton, Libero Vitiello
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in mdx Mice. Antioxidants (Basel, Switzerland) 13 (6) (2024)
Francesca Gasparella, Leonardo Nogara, Elena Germinario, Lucia Tibaudo, Stefano Ciciliot, Giorgia Piccoli, Francisca Carolina Venegas, Francesca Fontana, Gabriele Sales, Daniele Sabbatini, Jonathan S Foot, Wolfgang Jarolimek, Bert Blaauw, Marcella Canton, Libero Vitiello
A Novel MAO-B/SSAO Inhibitor Improves Multiple Aspects of Dystrophic Phenotype in mdx Mice. Antioxidants (Basel, Switzerland) 13 (6) (2024)
Alison D Findlay, Jonathan S Foot, Alberto Buson, Mandar Deodhar, Andrew G Jarnicki, Philip M Hansbro, Gang Liu, Heidi Schilter, Craig I Turner, Wenbin Zhou, Wolfgang Jarolimek
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3. Journal of medicinal chemistry 62 (21) (2019)